Dynamics in Post-pandemic Global Biosimilar Industry: Supply and Demand, Markets and Prices 2021-2027
Report Code: KNJ647430
Publisher: Date of Publish:
No. of Pages: 160 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Biosimilar market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Biosimilar market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Human Growth Hormones Monoclonal Antibodies Insulin Peptides Erythropoietin Others Segmented by End User/Segment Oncology Chronic and Autoimmune Diseases Growth Hormone Deficiency Infectious Diseases Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Pfizer Novartis Intas Pharmaceuticals Limited Genor BioPharma Dr. Reddy’s Laboratories Coherus BioSciences Celltrion Boehringer Ingelheim BioXpress Therapeutics Biocon BIOCAD Allergan plc
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Biosimilar Market Status and Forecast (2016-2027) 1.3.2 Global Biosimilar Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Biosimilar Supply by Company 2.1 Global Biosimilar Sales Volume by Company 2.2 Global Biosimilar Sales Value by Company 2.3 Global Biosimilar Price by Company 2.4 Biosimilar Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Biosimilar Market Status by Category 3.1 Biosimilar Category Introduction 3.1.1 Human Growth Hormones 3.1.2 Monoclonal Antibodies 3.1.3 Insulin 3.1.4 Peptides 3.1.5 Erythropoietin 3.1.6 Others 3.2 Global Biosimilar Market by Category 3.2.1 Global Biosimilar Sales Volume by Category (2016-2021) 3.2.2 Global Biosimilar Sales Value by Category (2016-2021) 3.2.3 Global Biosimilar Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category 4 Global and Regional Biosimilar Market Status by End User/Segment 4.1 Biosimilar Segment by End User/Segment 4.1.1 Oncology 4.1.2 Chronic and Autoimmune Diseases 4.1.3 Growth Hormone Deficiency 4.1.4 Infectious Diseases 4.1.5 Others 4.2 Global Biosimilar Market by End User/Segment 4.2.1 Global Biosimilar Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Biosimilar Sales Value by End User/Segment (2016-2021) 4.2.3 Global Biosimilar Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment 5 Global Biosimilar Market Status by Region 5.1 Global Biosimilar Market by Region 5.1.1 Global Biosimilar Sales Volume by Region 5.1.2 Global Biosimilar Sales Value by Region 5.2 North America Biosimilar Market Status 5.3 Europe Biosimilar Market Status 5.4 Asia Pacific Biosimilar Market Status 5.5 Central & South America Biosimilar Market Status 5.6 Middle East & Africa Biosimilar Market Status 6 North America Biosimilar Market Status 6.1 North America Biosimilar Market by Country 6.1.1 North America Biosimilar Sales Volume by Country (2016-2021) 6.1.2 North America Biosimilar Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Biosimilar Market Status 7.1 Europe Biosimilar Market by Country 7.1.1 Europe Biosimilar Sales Volume by Country (2016-2021) 7.1.2 Europe Biosimilar Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Biosimilar Market Status 8.1 Asia Pacific Biosimilar Market by Country 8.1.1 Asia Pacific Biosimilar Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Biosimilar Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Biosimilar Market Status 9.1 Central & South America Biosimilar Market by Country 9.1.1 Central & South America Biosimilar Sales Volume by Country (2016-2021) 9.1.2 Central & South America Biosimilar Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Biosimilar Market Status 10.1 Middle East & Africa Biosimilar Market by Country 10.1.1 Middle East & Africa Biosimilar Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Biosimilar Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Biosimilar Manufacturing Cost Analysis 11.5 Biosimilar Sales Channel and Distributors Analysis 11.5.1 Biosimilar Sales Channel 11.5.2 Biosimilar Distributors 11.6 Biosimilar Downstream Major Buyers 12 Global Biosimilar Market Forecast by Category and by End User/Segment 12.1 Global Biosimilar Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Biosimilar Forecast by Category 12.2.1 Global Biosimilar Sales Volume Forecast by Category 12.2.2 Global Biosimilar Sales Value Forecast by Category 12.2.3 Global Biosimilar Price Forecast by Category 12.3 Global Biosimilar Forecast by End User/Segment 12.3.1 Global Biosimilar Sales Volume Forecast by End User/Segment 12.3.2 Global Biosimilar Sales Value Forecast by End User/Segment 12.3.3 Global Biosimilar Price Forecast by End User/Segment 13 Global Biosimilar Market Forecast by Region/Country 13.1 Global Biosimilar Market Forecast by Region (2022-2027) 13.1.1 Global Biosimilar Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Biosimilar Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Pfizer 14.1.1 Company Information 14.1.2 Biosimilar Product Introduction 14.1.3 Pfizer Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Novartis 14.2.1 Company Information 14.2.2 Biosimilar Product Introduction 14.2.3 Novartis Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Intas Pharmaceuticals Limited 14.3.1 Company Information 14.3.2 Biosimilar Product Introduction 14.3.3 Intas Pharmaceuticals Limited Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Genor BioPharma 14.4.1 Company Information 14.4.2 Biosimilar Product Introduction 14.4.3 Genor BioPharma Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Dr. Reddy’s Laboratories 14.5.1 Company Information 14.5.2 Biosimilar Product Introduction 14.5.3 Dr. Reddy’s Laboratories Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Coherus BioSciences 14.6.1 Company Information 14.6.2 Biosimilar Product Introduction 14.6.3 Coherus BioSciences Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Celltrion 14.7.1 Company Information 14.7.2 Biosimilar Product Introduction 14.7.3 Celltrion Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Boehringer Ingelheim 14.8.1 Company Information 14.8.2 Biosimilar Product Introduction 14.8.3 Boehringer Ingelheim Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 BioXpress Therapeutics 14.9.1 Company Information 14.9.2 Biosimilar Product Introduction 14.9.3 BioXpress Therapeutics Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Biocon 14.10.1 Company Information 14.10.2 Biosimilar Product Introduction 14.10.3 Biocon Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 BIOCAD 14.12 Allergan plc 15 Conclusion 16 Methodology List of Tables and Figures Ask Sample Report to get more details…
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com